Back
Speaker illustration

undefined undefined undefined

Presentations

Therapeutic modulation of the lung microenvironment in obesity-induced heart failure with preserved ejection fraction

Event: ESC Congress 2025

Topic: Hypertension, Pulmonary Hypertension

Session: Cardiac remodeling and multiorgan interactions in heart failure

Access
Like
Thumbnail

The histone methyltransferase SETD2 promotes lipotoxic injury in cardiometabolic heart failure with preserved ejection fraction

Event: ESC Congress 2025

Topic: Heart Failure

Session: Mechanisms of cardiomyopathy and heart failure: from fibroblast dynamics to metabolic remodelling

Access
Like
Thumbnail

Employing epi-drugs to rescue lung microenvironmental changes in heart failure with preserved ejection fraction

Event: Heart Failure 2025

Topic: Pulmonary Hypertension

Session: ePosters in valvular and pulmonary

Access
Like
Thumbnail

Employing epi-drugs to rescue lung microenvironmental changes in heart failure with preserved ejection fraction

Event: HFA Winter Research Meeting on Translational Heart Failure 2025

Topic: Hypertension, Pulmonary Hypertension

Session: Young Investigator Award Poster Session

Access
Like
Thumbnail

Effects of BET Inhibition on lung micro-environmental changes in obesity-related pulmonary Arterial Hypertension (PAH)

Event: ESC Congress 2024

Topic: Hypertension, Pulmonary Hypertension

Session: Novel regulators of vascular functions

Access
Like
Thumbnail

Sacubitril/valsartan in an experimental model of heart failure with preserved ejection fraction

Event: Frontiers in CardioVascular Biomedicine 2022

Topic: Heart Failure

Session: Poster Session 1

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources